

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 5.93345445 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.24308369 |
| 3 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.15519883 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.55774743 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.31366214 |
| 6 | regulation of B cell differentiation (GO:0045577) | 4.29054416 |
| 7 | positive thymic T cell selection (GO:0045059) | 3.94006149 |
| 8 | positive regulation of B cell differentiation (GO:0045579) | 3.86801321 |
| 9 | regulation of antigen processing and presentation (GO:0002577) | 3.81981409 |
| 10 | B cell proliferation (GO:0042100) | 3.80224727 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.79828670 |
| 12 | defense response to protozoan (GO:0042832) | 3.77317435 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.75485357 |
| 14 | positive T cell selection (GO:0043368) | 3.72874005 |
| 15 | negative regulation of cell killing (GO:0031342) | 3.63701160 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.63701160 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.63530537 |
| 18 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.56184673 |
| 19 | L-fucose metabolic process (GO:0042354) | 3.54320612 |
| 20 | L-fucose catabolic process (GO:0042355) | 3.54320612 |
| 21 | fucose catabolic process (GO:0019317) | 3.54320612 |
| 22 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.52791292 |
| 23 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.52589817 |
| 24 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.52589817 |
| 25 | DNA deamination (GO:0045006) | 3.51414467 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.44995710 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 3.41856019 |
| 28 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.39390943 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.33397469 |
| 30 | behavioral response to nicotine (GO:0035095) | 3.32333089 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.31146431 |
| 32 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.28419985 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.19133894 |
| 34 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.18828890 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.18628815 |
| 36 | response to protozoan (GO:0001562) | 3.17408495 |
| 37 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.17100325 |
| 38 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.16307118 |
| 39 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.15323715 |
| 40 | T cell selection (GO:0045058) | 3.13023004 |
| 41 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.11384163 |
| 42 | negative regulation of mast cell activation (GO:0033004) | 3.05677196 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.05141497 |
| 44 | positive regulation of defense response to virus by host (GO:0002230) | 3.04658543 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.04476196 |
| 46 | regulation of germinal center formation (GO:0002634) | 3.04387002 |
| 47 | negative T cell selection (GO:0043383) | 3.04239605 |
| 48 | negative thymic T cell selection (GO:0045060) | 3.03704404 |
| 49 | positive regulation of granulocyte differentiation (GO:0030854) | 3.03413906 |
| 50 | regulation of B cell proliferation (GO:0030888) | 2.95001902 |
| 51 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.94056419 |
| 52 | activated T cell proliferation (GO:0050798) | 2.93667494 |
| 53 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.91919279 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 2.89135163 |
| 55 | B cell activation (GO:0042113) | 2.88096643 |
| 56 | negative regulation of T cell differentiation (GO:0045581) | 2.87356814 |
| 57 | negative regulation of B cell proliferation (GO:0030889) | 2.86014676 |
| 58 | B cell homeostasis (GO:0001782) | 2.84673708 |
| 59 | response to pheromone (GO:0019236) | 2.84634821 |
| 60 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.82544486 |
| 61 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.80686753 |
| 62 | indole-containing compound catabolic process (GO:0042436) | 2.78921062 |
| 63 | indolalkylamine catabolic process (GO:0046218) | 2.78921062 |
| 64 | tryptophan catabolic process (GO:0006569) | 2.78921062 |
| 65 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.76533834 |
| 66 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.75429429 |
| 67 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.75303664 |
| 68 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.74912755 |
| 69 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.73049250 |
| 70 | response to interleukin-15 (GO:0070672) | 2.70854802 |
| 71 | neural tube formation (GO:0001841) | 2.67434040 |
| 72 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.66662207 |
| 73 | positive regulation of B cell proliferation (GO:0030890) | 2.65450000 |
| 74 | thymic T cell selection (GO:0045061) | 2.63616133 |
| 75 | microglial cell activation (GO:0001774) | 2.62751404 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 2.62231492 |
| 77 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.62070502 |
| 78 | B cell mediated immunity (GO:0019724) | 2.59670603 |
| 79 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59627724 |
| 80 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.58852521 |
| 81 | negative regulation of telomere maintenance (GO:0032205) | 2.58695149 |
| 82 | cytidine deamination (GO:0009972) | 2.57458750 |
| 83 | cytidine metabolic process (GO:0046087) | 2.57458750 |
| 84 | cytidine catabolic process (GO:0006216) | 2.57458750 |
| 85 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.57163269 |
| 86 | positive regulation of B cell activation (GO:0050871) | 2.55494798 |
| 87 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.53248609 |
| 88 | negative regulation of adaptive immune response (GO:0002820) | 2.50624695 |
| 89 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.50443029 |
| 90 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.49174527 |
| 91 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.48825249 |
| 92 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.48825249 |
| 93 | modulation by symbiont of host immune response (GO:0052553) | 2.48825249 |
| 94 | positive regulation by symbiont of host defense response (GO:0052509) | 2.48825249 |
| 95 | modulation by symbiont of host defense response (GO:0052031) | 2.48825249 |
| 96 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.48825249 |
| 97 | detection of bacterium (GO:0016045) | 2.48040497 |
| 98 | regulation of defense response to virus by host (GO:0050691) | 2.47845182 |
| 99 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.46272030 |
| 100 | positive regulation of Rap GTPase activity (GO:0032854) | 2.45607262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.21515582 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.32289881 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.18826818 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.89903976 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.66675011 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.65025785 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.61558143 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.60298922 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26727256 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.10387279 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.03768496 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01349157 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.00722983 |
| 14 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.99803196 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.88888116 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86110838 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.82887512 |
| 18 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.73992763 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 1.63743969 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63016905 |
| 21 | GATA3_26560356_Chip-Seq_TH2_Human | 1.60655130 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.60514523 |
| 23 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.55356320 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52165013 |
| 25 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51584839 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49690714 |
| 27 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48843247 |
| 28 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47686121 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46036923 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.40802477 |
| 31 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.40706937 |
| 32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.39859713 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37776287 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.32100692 |
| 35 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.30444130 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29703502 |
| 37 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29171384 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.28433194 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27522226 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27211785 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27140698 |
| 42 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27056564 |
| 43 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.26557046 |
| 44 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26437065 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26072053 |
| 46 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.25203726 |
| 47 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25203726 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19377747 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.17881696 |
| 50 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17859670 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16878181 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.16789661 |
| 53 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.15126751 |
| 54 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13782836 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13566146 |
| 56 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.13072158 |
| 57 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12800839 |
| 58 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11716995 |
| 59 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11671262 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.11307065 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.11307065 |
| 62 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10971005 |
| 63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10953401 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10953401 |
| 65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10037599 |
| 66 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.09117515 |
| 67 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.08958443 |
| 68 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08928914 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07038953 |
| 70 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.06992039 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06286615 |
| 72 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05676766 |
| 73 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05530092 |
| 74 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05132185 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01999901 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01848347 |
| 77 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01039682 |
| 78 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00847282 |
| 79 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00452101 |
| 80 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98434427 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.98062924 |
| 82 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.97864511 |
| 83 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.95962709 |
| 84 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95847224 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94109686 |
| 86 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93922582 |
| 87 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93381808 |
| 88 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.93156127 |
| 89 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.91146617 |
| 90 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.90677317 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89953913 |
| 92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89953913 |
| 93 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89838262 |
| 94 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.88232187 |
| 95 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.87788700 |
| 96 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.87350876 |
| 97 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.87345363 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 0.87175835 |
| 99 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86941402 |
| 100 | ERA_21632823_ChIP-Seq_H3396_Human | 0.86778988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.88049509 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 3.55921299 |
| 3 | MP0001800_abnormal_humoral_immune | 3.54458903 |
| 4 | MP0001790_abnormal_immune_system | 3.39040379 |
| 5 | MP0005387_immune_system_phenotype | 3.39040379 |
| 6 | MP0005671_abnormal_response_to | 3.08165217 |
| 7 | MP0003787_abnormal_imprinting | 2.91751497 |
| 8 | MP0000685_abnormal_immune_system | 2.79054458 |
| 9 | MP0008877_abnormal_DNA_methylation | 2.66453463 |
| 10 | MP0001986_abnormal_taste_sensitivity | 2.51755301 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.47311744 |
| 12 | MP0002723_abnormal_immune_serum | 2.39395930 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.31337954 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.30522586 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.24750828 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.23580309 |
| 17 | MP0001819_abnormal_immune_cell | 2.18267881 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 2.03988171 |
| 19 | MP0001873_stomach_inflammation | 1.97235839 |
| 20 | MP0005310_abnormal_salivary_gland | 1.94515269 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.93140858 |
| 22 | MP0009785_altered_susceptibility_to | 1.82115784 |
| 23 | MP0002928_abnormal_bile_duct | 1.80289433 |
| 24 | MP0000716_abnormal_immune_system | 1.76447638 |
| 25 | MP0000689_abnormal_spleen_morphology | 1.76151292 |
| 26 | MP0002398_abnormal_bone_marrow | 1.71467811 |
| 27 | MP0003724_increased_susceptibility_to | 1.66756217 |
| 28 | MP0002653_abnormal_ependyma_morphology | 1.66512625 |
| 29 | MP0000372_irregular_coat_pigmentation | 1.64501272 |
| 30 | MP0005025_abnormal_response_to | 1.61820553 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.58678852 |
| 32 | MP0000015_abnormal_ear_pigmentation | 1.43184575 |
| 33 | MP0002405_respiratory_system_inflammati | 1.39489374 |
| 34 | MP0001968_abnormal_touch/_nociception | 1.38928633 |
| 35 | MP0003195_calcinosis | 1.37129063 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.33454745 |
| 37 | MP0003436_decreased_susceptibility_to | 1.31125117 |
| 38 | MP0002419_abnormal_innate_immunity | 1.30905137 |
| 39 | MP0008872_abnormal_physiological_respon | 1.30142154 |
| 40 | MP0002429_abnormal_blood_cell | 1.27800959 |
| 41 | MP0003303_peritoneal_inflammation | 1.26170835 |
| 42 | MP0004142_abnormal_muscle_tone | 1.25480107 |
| 43 | MP0002638_abnormal_pupillary_reflex | 1.23317311 |
| 44 | MP0002722_abnormal_immune_system | 1.22889545 |
| 45 | MP0004381_abnormal_hair_follicle | 1.21171931 |
| 46 | MP0005645_abnormal_hypothalamus_physiol | 1.20870171 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.20079620 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.19960721 |
| 49 | MP0004043_abnormal_pH_regulation | 1.13598399 |
| 50 | MP0003252_abnormal_bile_duct | 1.12011124 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.10922326 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.08193693 |
| 53 | MP0001663_abnormal_digestive_system | 1.07523965 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.06699734 |
| 55 | MP0003646_muscle_fatigue | 1.06507431 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.05614048 |
| 57 | MP0006292_abnormal_olfactory_placode | 1.05578175 |
| 58 | MP0009745_abnormal_behavioral_response | 1.03671353 |
| 59 | MP0009764_decreased_sensitivity_to | 1.02591880 |
| 60 | MP0002009_preneoplasia | 0.99896319 |
| 61 | MP0002102_abnormal_ear_morphology | 0.99779764 |
| 62 | MP0002095_abnormal_skin_pigmentation | 0.97213827 |
| 63 | MP0002693_abnormal_pancreas_physiology | 0.95003363 |
| 64 | MP0008995_early_reproductive_senescence | 0.94943724 |
| 65 | MP0009333_abnormal_splenocyte_physiolog | 0.92797513 |
| 66 | MP0000427_abnormal_hair_cycle | 0.92405750 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 0.92154682 |
| 68 | MP0000703_abnormal_thymus_morphology | 0.91939341 |
| 69 | MP0000465_gastrointestinal_hemorrhage | 0.91463381 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.89818725 |
| 71 | MP0003866_abnormal_defecation | 0.86069980 |
| 72 | MP0002166_altered_tumor_susceptibility | 0.79691620 |
| 73 | MP0004742_abnormal_vestibular_system | 0.78780001 |
| 74 | MP0001764_abnormal_homeostasis | 0.78234029 |
| 75 | MP0003121_genomic_imprinting | 0.76498634 |
| 76 | MP0002136_abnormal_kidney_physiology | 0.76296425 |
| 77 | MP0005253_abnormal_eye_physiology | 0.75914792 |
| 78 | MP0008961_abnormal_basal_metabolism | 0.75611791 |
| 79 | MP0000371_diluted_coat_color | 0.74951236 |
| 80 | MP0008469_abnormal_protein_level | 0.73494969 |
| 81 | MP0005646_abnormal_pituitary_gland | 0.73294385 |
| 82 | MP0001919_abnormal_reproductive_system | 0.73012432 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 0.72673346 |
| 84 | MP0002933_joint_inflammation | 0.71318693 |
| 85 | MP0006072_abnormal_retinal_apoptosis | 0.71272952 |
| 86 | MP0005389_reproductive_system_phenotype | 0.69603875 |
| 87 | MP0005085_abnormal_gallbladder_physiolo | 0.69208000 |
| 88 | MP0008057_abnormal_DNA_replication | 0.68830355 |
| 89 | MP0002837_dystrophic_cardiac_calcinosis | 0.68648901 |
| 90 | MP0002736_abnormal_nociception_after | 0.68351101 |
| 91 | MP0002254_reproductive_system_inflammat | 0.65241304 |
| 92 | MP0002067_abnormal_sensory_capabilities | 0.65085241 |
| 93 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64568539 |
| 94 | MP0004883_abnormal_blood_vessel | 0.63084546 |
| 95 | MP0002735_abnormal_chemical_nociception | 0.62005278 |
| 96 | MP0001905_abnormal_dopamine_level | 0.61227562 |
| 97 | MP0002733_abnormal_thermal_nociception | 0.60657654 |
| 98 | MP0002163_abnormal_gland_morphology | 0.60080262 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.57979642 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.57922592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 6.12155930 |
| 2 | Panhypogammaglobulinemia (HP:0003139) | 4.17710272 |
| 3 | Gastrointestinal stroma tumor (HP:0100723) | 4.04032729 |
| 4 | Recurrent bronchitis (HP:0002837) | 3.91416082 |
| 5 | Recurrent sinusitis (HP:0011108) | 3.79384383 |
| 6 | Meningitis (HP:0001287) | 3.59228675 |
| 7 | Congenital stationary night blindness (HP:0007642) | 3.49465284 |
| 8 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.38133958 |
| 9 | Pancreatic cysts (HP:0001737) | 3.37164642 |
| 10 | Chronic sinusitis (HP:0011109) | 3.30408256 |
| 11 | Lymphopenia (HP:0001888) | 3.21970242 |
| 12 | Verrucae (HP:0200043) | 3.01651457 |
| 13 | Papilloma (HP:0012740) | 3.01651457 |
| 14 | IgG deficiency (HP:0004315) | 2.98970807 |
| 15 | Vasculitis (HP:0002633) | 2.96691892 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.91684332 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 2.91684332 |
| 18 | Recurrent fungal infections (HP:0002841) | 2.91530238 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 2.86753495 |
| 20 | Bile duct proliferation (HP:0001408) | 2.81722610 |
| 21 | Abnormal biliary tract physiology (HP:0012439) | 2.81722610 |
| 22 | Abnormality of B cell number (HP:0010975) | 2.81206246 |
| 23 | Abnormality of midbrain morphology (HP:0002418) | 2.80676709 |
| 24 | Molar tooth sign on MRI (HP:0002419) | 2.80676709 |
| 25 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.77890787 |
| 26 | Hyperventilation (HP:0002883) | 2.75473935 |
| 27 | Stomatitis (HP:0010280) | 2.74509684 |
| 28 | Stomach cancer (HP:0012126) | 2.72053401 |
| 29 | Pancreatic fibrosis (HP:0100732) | 2.65892205 |
| 30 | Colitis (HP:0002583) | 2.63580368 |
| 31 | Recurrent pneumonia (HP:0006532) | 2.63064771 |
| 32 | Encephalitis (HP:0002383) | 2.62827137 |
| 33 | Abnormality of the prostate (HP:0008775) | 2.57857458 |
| 34 | Inflammation of the large intestine (HP:0002037) | 2.54240732 |
| 35 | Nephronophthisis (HP:0000090) | 2.52179967 |
| 36 | Chronic diarrhea (HP:0002028) | 2.50144388 |
| 37 | Recurrent bacterial skin infections (HP:0005406) | 2.48391466 |
| 38 | True hermaphroditism (HP:0010459) | 2.46105052 |
| 39 | Recurrent viral infections (HP:0004429) | 2.43265182 |
| 40 | Chronic otitis media (HP:0000389) | 2.42117010 |
| 41 | B lymphocytopenia (HP:0010976) | 2.41962208 |
| 42 | Bronchitis (HP:0012387) | 2.40763281 |
| 43 | Thyroiditis (HP:0100646) | 2.40314095 |
| 44 | Abnormality of the renal cortex (HP:0011035) | 2.39662753 |
| 45 | Hypoplasia of the thymus (HP:0000778) | 2.38126587 |
| 46 | Attenuation of retinal blood vessels (HP:0007843) | 2.37113581 |
| 47 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.34146965 |
| 48 | Abnormality of the renal medulla (HP:0100957) | 2.31441280 |
| 49 | Severe combined immunodeficiency (HP:0004430) | 2.31427807 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.27391276 |
| 51 | Cellulitis (HP:0100658) | 2.25520775 |
| 52 | Abnormality of T cells (HP:0002843) | 2.24060648 |
| 53 | Abnormal drinking behavior (HP:0030082) | 2.21647156 |
| 54 | Polydipsia (HP:0001959) | 2.21647156 |
| 55 | T lymphocytopenia (HP:0005403) | 2.20431970 |
| 56 | Abnormality of T cell number (HP:0011839) | 2.19266301 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.16260353 |
| 58 | Pustule (HP:0200039) | 2.14687799 |
| 59 | Chronic hepatic failure (HP:0100626) | 2.14532573 |
| 60 | Recurrent skin infections (HP:0001581) | 2.10693844 |
| 61 | Osteomyelitis (HP:0002754) | 2.10312585 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.09251847 |
| 63 | Optic neuritis (HP:0100653) | 2.09251847 |
| 64 | Restrictive lung disease (HP:0002091) | 2.05962274 |
| 65 | Emphysema (HP:0002097) | 2.05130283 |
| 66 | Recurrent lower respiratory tract infections (HP:0002783) | 2.04798137 |
| 67 | Tubular atrophy (HP:0000092) | 2.04590801 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.03549459 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 2.01994352 |
| 70 | Hematochezia (HP:0002573) | 2.01643914 |
| 71 | Sepsis (HP:0100806) | 2.00685596 |
| 72 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.99711486 |
| 73 | Neutropenia (HP:0001875) | 1.98325260 |
| 74 | Cystic liver disease (HP:0006706) | 1.97209021 |
| 75 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.95956608 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 1.94942920 |
| 77 | Obstructive lung disease (HP:0006536) | 1.94905179 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 1.94905179 |
| 79 | Abolished electroretinogram (ERG) (HP:0000550) | 1.92719643 |
| 80 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.92310620 |
| 81 | Medial flaring of the eyebrow (HP:0010747) | 1.91434931 |
| 82 | Asplenia (HP:0001746) | 1.90991976 |
| 83 | Hemoptysis (HP:0002105) | 1.88501318 |
| 84 | Type II lissencephaly (HP:0007260) | 1.88392093 |
| 85 | Myositis (HP:0100614) | 1.85255246 |
| 86 | Hypoproteinemia (HP:0003075) | 1.84812826 |
| 87 | Progressive inability to walk (HP:0002505) | 1.82245463 |
| 88 | Abnormality of eosinophils (HP:0001879) | 1.81878539 |
| 89 | Gaze-evoked nystagmus (HP:0000640) | 1.81201668 |
| 90 | Absent speech (HP:0001344) | 1.80729899 |
| 91 | Abnormality of the pleura (HP:0002103) | 1.78477336 |
| 92 | Inability to walk (HP:0002540) | 1.77635833 |
| 93 | Febrile seizures (HP:0002373) | 1.76991087 |
| 94 | Polyuria (HP:0000103) | 1.75581112 |
| 95 | Alveolar cell carcinoma (HP:0006519) | 1.75420058 |
| 96 | Skin rash (HP:0000988) | 1.72594499 |
| 97 | Eczematoid dermatitis (HP:0000976) | 1.72577825 |
| 98 | Lymphoma (HP:0002665) | 1.72539144 |
| 99 | Recurrent otitis media (HP:0000403) | 1.72496106 |
| 100 | Decreased circulating renin level (HP:0003351) | 1.72274882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.49252442 |
| 2 | BLK | 4.47457182 |
| 3 | FRK | 3.59713853 |
| 4 | TXK | 3.14062431 |
| 5 | RIPK4 | 2.91317452 |
| 6 | IRAK4 | 2.77799227 |
| 7 | SYK | 2.35371150 |
| 8 | GRK1 | 2.20191420 |
| 9 | MAP4K2 | 2.02685039 |
| 10 | ADRBK2 | 1.99062843 |
| 11 | BTK | 1.88919174 |
| 12 | IKBKE | 1.78608193 |
| 13 | BMPR2 | 1.71726496 |
| 14 | MST4 | 1.71487807 |
| 15 | TNK2 | 1.66106077 |
| 16 | TAOK3 | 1.60469137 |
| 17 | TEC | 1.49909362 |
| 18 | ITK | 1.49773462 |
| 19 | ACVR1B | 1.49627036 |
| 20 | GRK6 | 1.47250792 |
| 21 | WNK3 | 1.47210280 |
| 22 | LYN | 1.45785539 |
| 23 | SIK3 | 1.44711220 |
| 24 | CSF1R | 1.44004460 |
| 25 | MAPK13 | 1.38777054 |
| 26 | WNK4 | 1.38629859 |
| 27 | SIK2 | 1.38094001 |
| 28 | IKBKB | 1.37594833 |
| 29 | BMPR1B | 1.36360846 |
| 30 | ERN1 | 1.35586703 |
| 31 | NUAK1 | 1.35425493 |
| 32 | TYK2 | 1.33107058 |
| 33 | TLK1 | 1.31092853 |
| 34 | JAK3 | 1.27580381 |
| 35 | IRAK1 | 1.26717438 |
| 36 | MARK3 | 1.22888555 |
| 37 | INSRR | 1.19280391 |
| 38 | PRKCQ | 1.15024447 |
| 39 | ZAK | 1.12332462 |
| 40 | PINK1 | 1.09069490 |
| 41 | OXSR1 | 1.07636245 |
| 42 | CAMKK2 | 1.03140255 |
| 43 | TRIM28 | 1.02387894 |
| 44 | HCK | 1.02243381 |
| 45 | LCK | 1.01558306 |
| 46 | FES | 0.90921215 |
| 47 | STK39 | 0.87034198 |
| 48 | NLK | 0.86758793 |
| 49 | ADRBK1 | 0.85108510 |
| 50 | PIK3CG | 0.84202918 |
| 51 | KIT | 0.82052042 |
| 52 | MAP3K10 | 0.77696656 |
| 53 | PAK3 | 0.74317416 |
| 54 | MAPK15 | 0.73650684 |
| 55 | CHUK | 0.71285508 |
| 56 | MAP3K13 | 0.66016896 |
| 57 | CSK | 0.64784354 |
| 58 | CASK | 0.64253608 |
| 59 | NTRK3 | 0.62556562 |
| 60 | PKN1 | 0.61716724 |
| 61 | MAP3K14 | 0.60949156 |
| 62 | STK11 | 0.59661460 |
| 63 | MAP3K4 | 0.58249995 |
| 64 | ABL1 | 0.55326448 |
| 65 | PIM1 | 0.52503940 |
| 66 | MAPK12 | 0.52007369 |
| 67 | JAK1 | 0.51190984 |
| 68 | IRAK2 | 0.50791553 |
| 69 | SGK2 | 0.50733212 |
| 70 | TBK1 | 0.50697436 |
| 71 | DYRK1A | 0.49310741 |
| 72 | ZAP70 | 0.49146290 |
| 73 | CAMK1 | 0.48324778 |
| 74 | PDK1 | 0.44679507 |
| 75 | MAP2K2 | 0.43348308 |
| 76 | PTK2B | 0.42968319 |
| 77 | PASK | 0.42426552 |
| 78 | JAK2 | 0.42150702 |
| 79 | MAP3K7 | 0.39400673 |
| 80 | MAP2K6 | 0.39104621 |
| 81 | FYN | 0.39028125 |
| 82 | MAP2K1 | 0.38637860 |
| 83 | HIPK2 | 0.37749203 |
| 84 | PRKCZ | 0.37512757 |
| 85 | STK10 | 0.36344440 |
| 86 | BRSK2 | 0.36192255 |
| 87 | DAPK2 | 0.34643297 |
| 88 | FGFR2 | 0.34131791 |
| 89 | DYRK2 | 0.33542451 |
| 90 | CSNK1A1 | 0.32723199 |
| 91 | MAPK7 | 0.32146070 |
| 92 | MAPK11 | 0.31777781 |
| 93 | PRKCE | 0.31115228 |
| 94 | PDK2 | 0.30971404 |
| 95 | CAMKK1 | 0.30220133 |
| 96 | MARK2 | 0.28794123 |
| 97 | DYRK1B | 0.28670678 |
| 98 | CDC42BPA | 0.27316592 |
| 99 | MAPKAPK3 | 0.27245393 |
| 100 | PRKACA | 0.27070981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.14160315 |
| 2 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.05797483 |
| 3 | Asthma_Homo sapiens_hsa05310 | 4.01176200 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.85063797 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.72004396 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.65552200 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.24197415 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.80025006 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.73425867 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.25960331 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.25390192 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.09229933 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80427367 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 1.73859247 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.69031740 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.61748215 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.58715932 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56330523 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.48978468 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33964101 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.26195039 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20774029 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15693285 |
| 24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.13137848 |
| 25 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12691547 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.11416739 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09653400 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06843977 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.06703024 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06047214 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05642654 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05121134 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01910176 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94097702 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90489950 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90422514 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 0.89551979 |
| 38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87176523 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86837061 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85475755 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.85291702 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 0.82574134 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81065498 |
| 44 | Homologous recombination_Homo sapiens_hsa03440 | 0.80708537 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78459788 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76792406 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.76416435 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74808406 |
| 49 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70865498 |
| 50 | Measles_Homo sapiens_hsa05162 | 0.68463759 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67638479 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 0.67435019 |
| 53 | Taste transduction_Homo sapiens_hsa04742 | 0.66784372 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65445434 |
| 55 | Nicotine addiction_Homo sapiens_hsa05033 | 0.64272246 |
| 56 | Morphine addiction_Homo sapiens_hsa05032 | 0.63836558 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61986910 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.61658079 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.60400597 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60298118 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57993656 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.56830582 |
| 63 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.56507790 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56311587 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55638257 |
| 66 | Basal transcription factors_Homo sapiens_hsa03022 | 0.54828342 |
| 67 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52523254 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51971611 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.51443547 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51388530 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51088510 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50720755 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46588596 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44693032 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43748526 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42546846 |
| 77 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.38889881 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.35282984 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.33802780 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32934488 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31120288 |
| 82 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.29611418 |
| 83 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.29064526 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27846296 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.27593865 |
| 86 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.27491999 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.25798358 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25562787 |
| 89 | Long-term depression_Homo sapiens_hsa04730 | 0.24595403 |
| 90 | Protein export_Homo sapiens_hsa03060 | 0.23737919 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23203169 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.22517698 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22321527 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.21819527 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.21609747 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.21438463 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.21367129 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20670577 |
| 99 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.19242584 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.17416003 |

